CF45776-61 - 0x00000000000069D6

Males & Females of Non-Childbearing Potential

Nutshell

* El estipendio puede pagar hasta el monto reflejado.
Start Date: 
January 20, 2026 - 2:00pm
End Date: 
February 17, 2026 - 11:30am

Study Details

Study Number: CF45776
Group Number: 61
Study Requirement: Healthy Normal Male and Female
Stipend: up to $11,500.00

Study Criteria

Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat cancer.
Route of Administration: Oral
Blood Draws: 30

Study Schedule

Schedule Type: Long Term
Study Length: One -15 Night Stay & 1 Phone Call

Screening Dates:

Event Day Event Date
Wednesday 12/31/2025
Tuesday 1/6/2026
Wednesday 1/7/2026
Thursday 1/8/2026

Doctor Exam Dates:

Event Day Event Date
Thursday 1/8/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Tuesday 1/20/2026 2:00:00 PM Wednesday 2/4/2026 3:00:00 PM 1 Lincoln
Phone participant Tuesday 2/17/2026 11:30:00 AM 1 Lincoln